ArticleFrontiers in pediatrics2026
Association between a four-locus gene model including
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to explore the association between a four-locus gene model and asthma outcomes. Methods: Four single-nucleotide polymorphisms were genotyped in 139 patients with different asthma outcomes (clinical remission, relapse, or persistence). The high-risk and low-risk genotypes for asthma were evaluated according to the different genotypes that they carried. Differences in asthma outcomes and the factors affecting asthma prognosis were analyzed. Results: More patients with high-risk genotypes had severe asthma attacks than those with low-risk genotypes. Compared with patients in asthma clinical remission, patients with severe asthma attacks were at risk for asthma relapse and asthma persistence. In addition, smoking was a risk factor for asthma persistence. The older the age of asthma onset, the more likely it was to be persistent. More patients in the high-risk genotype group had an age of asthma onset younger than 6 years old and an asthma course longer than 4 years than in the low-risk genotype group, regardless of the confounding factors. Conclusions: The patients with high-risk genotypes not only had more severe asthma attacks and a younger age of asthma onset but also had a longer course, which suggested that the gene model could serve as a tool for asthma prognosis assessment with moderate utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.